IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis

The therapeutic effect of mesenchymal stem cells (MSCs) in multiple sclerosis (MS) and the experimental autoimmune encephalomyelitis (EAE) model has been well described. This effect is, in part, mediated through the inhibition of IL17-producing cells and the generation of regulatory T cells. While p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurte, Mónica, Luz-Crawford, Patricia, Vega-Letter, Ana María, Contreras, Rafael A., Tejedor, Gautier, Elizondo-Vega, Roberto, Martinez-Viola, Luna, Fernández-O’Ryan, Catalina, Figueroa, Fernando E., Jorgensen, Christian, Djouad, Farida, Carrión, Flavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936796/
https://www.ncbi.nlm.nih.gov/pubmed/29760692
http://dx.doi.org/10.3389/fimmu.2018.00802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936796/
https://www.ncbi.nlm.nih.gov/pubmed/29760692
http://dx.doi.org/10.3389/fimmu.2018.00802

Ejemplares similares